Skip to content
Clinical Trials – home

Clonazepam: A Comprehensive Guide for Patients

4 / 4
trials open to patients / all trials
5+
Countries

In short

Clonazepam, a medication belonging to the benzodiazepine class, has been the subject of numerous clinical trials investigating its efficacy and safety in treating various medical conditions. These trials have explored its use in epilepsy, sleep disorders, psychiatric conditions, and even as a potential treatment for cannabis use disorder. This article summarizes key findings from recent clinical trials involving clonazepam, providing insights into its diverse applications in medical research.

What is Clonazepam?

Clonazepam is a medication that belongs to a class of drugs called benzodiazepines. It is known by various brand names, including Klonopin, Rivotril, and Klonopin Wafers. Clonazepam is available in different forms, including tablets, orally disintegrating tablets (ODT), and wafers, which dissolve in the mouth.

Medical Uses of Clonazepam

Clonazepam is prescribed for various medical conditions, including:

  • Panic Disorder: It is used to treat panic attacks and anxiety disorders, with or without agoraphobia (fear of open or crowded spaces).
  • Epilepsy: Clonazepam is effective in managing certain types of seizures, including generalized tonic-clonic seizures (formerly known as grand mal seizures).
  • REM Sleep Behavior Disorder (RBD): This condition, often associated with Parkinson's disease, causes people to act out their dreams. Clonazepam has shown effectiveness in treating RBD.
  • Burning Mouth Syndrome (BMS): Some studies have investigated the use of clonazepam in treating this chronic pain condition affecting the mouth.

How Clonazepam Works

Clonazepam works by enhancing the effects of a neurotransmitter called GABA (gamma-aminobutyric acid) in the brain. GABA is a chemical that helps calm brain activity. By increasing GABA's effects, clonazepam can reduce anxiety, prevent seizures, and promote relaxation.

Dosage and Administration

The dosage of clonazepam varies depending on the condition being treated and the individual patient's response. Some common dosages include:

  • For panic disorder: 0.5 mg to 2 mg per day, often divided into two doses.
  • For epilepsy: Dosages can range from 0.5 mg to 20 mg per day, depending on the severity of the condition.
  • For REM sleep behavior disorder: Typically, a low dose of 0.5 mg to 1 mg before bedtime.

It's crucial to follow your doctor's instructions precisely and never adjust your dosage without consulting your healthcare provider.

Potential Side Effects

Like all medications, clonazepam can cause side effects. Common side effects may include:

  • Drowsiness or sleepiness
  • Dizziness
  • Unsteadiness or coordination problems
  • Memory problems
  • Increased saliva production

More serious side effects, though rare, can include mood changes, depression, or suicidal thoughts. If you experience any severe or persistent side effects, contact your doctor immediately.

Precautions and Considerations

There are several important considerations when taking clonazepam:

  • Dependency and withdrawal: Clonazepam can be habit-forming. Long-term use may lead to physical dependence, and stopping the medication abruptly can cause withdrawal symptoms. Always work with your doctor to gradually reduce the dose if you need to stop taking it.
  • Interactions: Clonazepam can interact with other medications, including opioids, alcohol, and certain antidepressants. Always inform your doctor about all medications you're taking.
  • Pregnancy and breastfeeding: Clonazepam may pose risks during pregnancy and breastfeeding. Discuss the potential risks and benefits with your doctor if you're pregnant or planning to become pregnant.

Ongoing Research

Researchers continue to study clonazepam for various conditions:

  • Cannabis Use Disorder: A study is investigating whether clonazepam can help manage withdrawal symptoms and prevent relapse in people trying to quit cannabis use.
  • Schizophrenia: Researchers are exploring whether low doses of clonazepam might improve cognitive function in people with schizophrenia.
  • Status Epilepticus: This is a severe, prolonged seizure condition. Studies are looking at using clonazepam in combination with other medications for rapid treatment of this condition.

These ongoing studies may lead to new uses for clonazepam in the future, but it's important to remember that the medication should only be used as prescribed by a healthcare professional for approved conditions.

Questions people often ask

Conditions where Clonazepam is being studied

Each condition opens its own overview and trial list

Trials with Clonazepam

Recruiting trials first

See all 4 →
Quick filters
  • Participants:Adults · Healthy volunteers
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).